The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.
Frontiers in molecular biosciences
View this publicationFrontiers in molecular biosciences
View this publicationJournal of extracellular vesicles
View this publicationClinical and translational allergy
View this publicationThe FEBS journal
View this publicationAmerican journal of respiratory and critical care medicine
View this publicationCell reports. Medicine
View this publicationMolecular therapy. Nucleic acids
View this publicationEuropean journal of immunology
View this publicationFrontiers in chemistry
View this publicationCellular & molecular immunology
View this publication